Both in R&D — Physical & Biological Sciences
bioAffinity Technologies vs IB Acquisition
Over the past year BIAF returned −92.4% and IBAC returned +4.0%; their daily moves had a correlation of 0.02.
BIAF −92.4% IBAC +4.0%Growth of $1, one year, split-adjusted
| Metric | BIAF | IBAC |
|---|---|---|
| Price | $3.14 | $10.86 |
| Market cap | $1.9M | $54.4M |
| Today | +6.08% | 0.00% |
| 1 month | −54.4% | −2.2% |
| 6 months | −91.4% | +0.7% |
| Year to date | −82.3% | +3.4% |
| 1 year | −91.9% | — |
| Revenue growth (YoY) | +19.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −222.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | $1.8M | — |
| Dividend yield | — | — |
| Volatility (60d) | 825.7% | 20.1% |
| Short % of float | 11.4% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).